Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
PLoS One. 2013 Sep 16;8(9):e73230. doi: 10.1371/journal.pone.0073230. eCollection 2013.
Biomarker host genetic signatures are considered key tools for improved early diagnosis of tuberculosis (TB) disease (development). The analysis of gene expression changes based on a limited number of genes or single study designs, however, may not be sufficient for the identification of universal diagnostic biomarker profiles. Here we propose that biological pathway and process based analyses from multiple data sets may be more relevant for identification of key pathways in TB pathogenesis, and may reveal novel candidate diagnostic TB biomarkers. A number of independent genome-wide gene expression studies have recently been performed to study expression of biomarkers for TB disease. We have integrated the results from these independent studies and performed pathway- as well as biological process-based analysis on the total data set. Interestingly, IFNα/β signalling is not the single dominant pathway in the analysis of the total dataset, but combined, functional, analysis of biomarkers suggests a strong dominant role for myeloid cell involvement in inflammation.
生物标志物宿主遗传特征被认为是提高结核病(TB)疾病早期诊断的关键工具(发展)。然而,基于少数基因或单一研究设计的基因表达变化分析可能不足以确定通用的诊断生物标志物特征。在这里,我们提出,基于多个数据集的生物途径和过程分析可能更有助于确定 TB 发病机制中的关键途径,并可能揭示新的候选诊断性 TB 生物标志物。最近已经进行了许多独立的全基因组基因表达研究,以研究 TB 疾病的生物标志物表达。我们整合了这些独立研究的结果,并对整个数据集进行了基于途径和基于生物学过程的分析。有趣的是,IFNα/β信号通路并不是整个数据集分析中的唯一主导途径,而是生物标志物的综合功能分析表明,髓样细胞参与炎症具有很强的主导作用。